Yes, they do. However, they have no reason to believe the compound will work better for more advanced AD patients than for those with early stage. I'd even say quite the contrary.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.